A model to strengthen utility of quality pharmaceutical health systems data in resource-limited settings.

Harriet Rachel Kagoya Dan KibuuleTimothy William RennieHonoré Kabwebwe Mitonga

Published in: Medicine access @ point of care (2020)

While utility of quality PIS data is limited in Namibia, advantages of the model are encouraging, toward building resilient pharmaceutical intelligence systems at grass roots in resource-limited countries, where there are not only weak health systems, but high burden of misuse of medicines.

Keyphrases

electronic health record
quality improvement
machine learning
risk factors
deep learning
cell wall